Another study showed that hospitalized patients with hyperglycemia treated with an insulin infusion had a lower risk of death from COVID-19 than patients who did not receive an insulin infusion, most likely due to a decrease in inflammatory mediators [29]. This evidence concerns the gene INS and Hyperglycemia.